Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: A phase III, randomized study

por Abu-Elyazeed, Remon, Jennings, William, Severance, Randall, Noss, Michael, Caplanusi, Adrian, Povey, Michael, Henry, Ouzama
Publicado 2018

Assessment of Mumps Virus-Specific Antibodies: Comparison of Plaque Reduction Neutralization Test and Enzyme-Linked Immunosorbent Assay Estimates

por Ravault, Stéphanie, Friel, Damien, Di Paolo, Emmanuel, Caplanusi, Adrian, Gillard, Paul, Povey, Michael, Carryn, Stephane
Publicado 2019

Flexibility of interval between vaccinations with AS03(A)-adjuvanted influenza A (H1N1) 2009 vaccine in adults aged 18–60 and >60 years: a randomized trial

por Duval, Xavier, Caplanusi, Adrian, Laurichesse, Henri, Deplanque, Dominique, Loulergue, Pierre, Vaman, Tejaswini, Launay, Odile, Gillard, Paul
Publicado 2012

An assessment of prime‐boost vaccination schedules with AS03(A)‐adjuvanted prepandemic H5N1 vaccines: a randomized study in European adults

por Gillard, Paul, Caplanusi, Adrian, Knuf, Markus, Roman, François, Walravens, Karl, Moris, Philippe, Dramé, Mamadou, Schwarz, Tino F.
Publicado 2012

A phase III randomized, open-label, non-inferiority clinical trial comparing liquid and lyophilized formulations of oral live attenuated human rotavirus vaccine (HRV) in Indian inf...

por Cohet, Catherine, Cheuvart, Brigitte, Moerman, Leentje, Bi, Dan, Caplanusi, Adrian, Kariyappa, Mallesh, Lalwani, Sanjay, Mitra, Monjori, Sapru, Amita, Saha, Shruti, Varughese, P.V., Kompithra, Rajeev Zachariah, Gandhi, Sanjay
Publicado 2021

Safety and persistence of the humoral and cellular immune responses induced by 2 doses of an AS03-adjuvanted A(H1N1)pdm09 pandemic influenza vaccine administered to infants, childr...

por Garcia-Sicilia, José, Arístegui, Javier, Omeñaca, Félix, Carmona, Alfonso, Tejedor, Juan C, Merino, José M, García-Corbeira, Pilar, Walravens, Karl, Bambure, Vinod, Moris, Philippe, Caplanusi, Adrian, Gillard, Paul, Dieussaert, Ilse
Publicado 2015

Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: result...

por Launay, Odile, Duval, Xavier, Fitoussi, Serge, Jilg, Wolfgang, Kerdpanich, Angkool, Montellano, May, Schwarz, Tino F, Watanveerade, Veerachai, Wenzel, Jürgen J, Zalcman, Gerard, Bambure, Vinod, Li, Ping, Caplanusi, Adrian, Madan, Anuradha, Gillard, Paul, Vaughn, David W
Publicado 2013

Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Cons...

por Klein, Nicola P, Abu-Elyazeed, Remon, Povey, Michael, Macias Parra, Mercedes, Diez-Domingo, Javier, Ahonen, Anitta, Korhonen, Tiina, Tinoco, Juan-Carlos, Weiner, Leonard, Marshall, Gary S, Silas, Peter E, Sarpong, Kwabena O, Ramsey, Keith P, Fling, John A, Speicher, David, Campos, Maribel, Munjal, Iona, Peltier, Christopher, Vesikari, Timo, Baccarini, Carmen, Caplanusi, Adrian, Gillard, Paul, Carryn, Stephane, Henry, Ouzama
Publicado 2019